Alexander Mironov - 27 Jan 2022 Form 4 Insider Report for LifeMD, Inc. (LFMD)

Reporting relationship: President
Issuer ticker: LFMD
Reported as of: 27 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Aug 2023, 17:14:59 UTC
Prior SEC filing: 14 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Alexander Mironov

Key filing fact

Alexander Mironov filed Form 4 for LifeMD, Inc. (LFMD) on 01 Aug 2023.

Key facts

This page summarizes Alexander Mironov's Form 4 filing for LifeMD, Inc. (LFMD).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 01 Aug 2023, 17:14.

Change

Previous filing in this sequence was filed on 14 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LFMD transaction

Common Stock

Award

Transaction value
Shares: +50,000
Change %: +201%
Price
Shares after: 74,857
Date: 27 Jan 2022
Ownership: Direct
Footnotes: F1

LFMD transaction

Common Stock

Award

Transaction value
Shares: +50,000
Change %: +67%
Price
Shares after: 124,857
Date: 28 Jul 2023
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares result from the vesting of performance-based restricted stock which vested on January 27, 2022. Each restricted stock share is equivalent to one share of the Company's common stock.

Footnote F2

The shares result from an accelerated vesting of restricted stock. Each restricted stock share is equivalent to one share of the Company's common stock.